Marina Biotech, Inc. (MRNA) Reports Q3 Loss of $0.05
November 10, 2011 7:42 AM
Marina Biotech, Inc. (NASDAQ: MRNA) reported Q3 EPS of ($0.05), versus ($0.39) reported last year. Revenue for the quarter came in at $286 thousand, versus $1.13 million reported last year.
